In this population-based cohort of premenopausal breast cancer survivors with non-distant metastatic breast cancer, homozygous carriers of CYP3A5 rs776746 had delayed return-to-work and stable labor market attachment after breast cancer. Here, CYP3A5 is linked to breast carcinoma.